US Stock MarketDetailed Quotes

NVNBW ENVVENO MED CORP C/WTS 11/02/2026 (TO PUR COM)

Watchlist
  • 1.000
  • 0.0000.00%
15min DelayClose Aug 9 16:00 ET
0Market Cap0.00P/E (TTM)

ENVVENO MED CORP C/WTS 11/02/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
15.35%6.17M
-19.96%5.45M
-19.04%5.5M
1.23%25.24M
-2.82%6.28M
-13.04%5.35M
-2.46%6.81M
27.40%6.8M
47.59%24.93M
-28.17%6.46M
Selling and administrative expenses
29.79%3.31M
1.12%2.63M
-23.45%2.45M
-22.39%11.66M
-9.99%3.3M
-30.28%2.55M
-33.55%2.6M
-15.36%3.2M
34.51%15.02M
-49.20%3.66M
Research and development costs
2.18%2.86M
-32.96%2.83M
-15.10%3.05M
37.01%13.58M
6.58%2.98M
12.28%2.8M
37.13%4.21M
131.64%3.6M
73.08%9.91M
56.96%2.8M
Operating profit
-15.35%-6.17M
19.96%-5.45M
19.04%-5.5M
-1.23%-25.24M
2.82%-6.28M
13.04%-5.35M
2.46%-6.81M
-27.40%-6.8M
-47.59%-24.93M
28.17%-6.46M
Net non-operating interest income expense
113.64%94K
87.18%73K
31.11%59K
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
Non-operating interest income
113.64%94K
87.18%73K
31.11%59K
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
Other net income (expense)
42.76%434K
41.20%425K
25.56%452K
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
360K
-70.52%102K
236K
Gain on sale of security
42.76%434K
41.20%425K
25.56%452K
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
--360K
--102K
--236K
Income before tax
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
Income tax
Net income
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
Net income continuous Operations
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
Minority interest income
Net income attributable to the parent company
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 15.35%6.17M-19.96%5.45M-19.04%5.5M1.23%25.24M-2.82%6.28M-13.04%5.35M-2.46%6.81M27.40%6.8M47.59%24.93M-28.17%6.46M
Selling and administrative expenses 29.79%3.31M1.12%2.63M-23.45%2.45M-22.39%11.66M-9.99%3.3M-30.28%2.55M-33.55%2.6M-15.36%3.2M34.51%15.02M-49.20%3.66M
Research and development costs 2.18%2.86M-32.96%2.83M-15.10%3.05M37.01%13.58M6.58%2.98M12.28%2.8M37.13%4.21M131.64%3.6M73.08%9.91M56.96%2.8M
Operating profit -15.35%-6.17M19.96%-5.45M19.04%-5.5M-1.23%-25.24M2.82%-6.28M13.04%-5.35M2.46%-6.81M-27.40%-6.8M-47.59%-24.93M28.17%-6.46M
Net non-operating interest income expense 113.64%94K87.18%73K31.11%59K11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K
Non-operating interest income 113.64%94K87.18%73K31.11%59K11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K
Other net income (expense) 42.76%434K41.20%425K25.56%452K1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K360K-70.52%102K236K
Gain on sale of security 42.76%434K41.20%425K25.56%452K1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K--360K--102K--236K
Income before tax -12.82%-5.64M23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M
Income tax
Net income -12.82%-5.64M23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M
Net income continuous Operations -12.82%-5.64M23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M
Minority interest income
Net income attributable to the parent company -12.82%-5.64M23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.82%-5.64M23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data